Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pills, injections

Well, as you highlighted, HIMS cratering while Novo shares pop. The pharma giant filing a lawsuit this morning against the tellahalth company, asking the court to permanently ban HIMS from selling all compounded versions of its drugs, citing patent infringement. The FDA, which referred HIMS to the DOJ on Friday, also threatened legal action.Now, in response over the weekend, HIMS said they would pull their GLP-1 oral medicine that they announced only a few days prior. Novo in the complaint saying, "Other ph ...